Drugs / Oxycodone/Naloxone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03768466 | Nov 2018 → Feb 2020 | — | Mundipharma Korea Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxycodone/Naloxone | “Brand Name: Targin® Generic name: Oxycodone/Naloxone dosage form: Oral” NCT03768466 ↗ |
| Known as | Targin | “Brand Name: Targin® Generic name: Oxycodone/Naloxone dosage form: Oral” NCT03768466 ↗ |
| Route | Oral | “dosage form: Oral” NCT03768466 ↗ |